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Oxidative stress has been postulated as a mechanism of
organ dysfunction - and thus a potential therapeutic
target - in sepsis. Lorente and colleagues report
increased serum levels of malondialdehyde, a biomarker
of oxidative stress-induced lipid peroxidation, in adults
with severe sepsis, particularly in non-survivors. While
survivors exhibited a decrease in serum malondialdehyde
over time, the elevation was sustained in non-survivors.
These findings suggest that there is increased oxidative
stress in sepsis and that membrane lipids in particular
are targeted by free radical species. Further study is
required to validate the utility of malondialdehyde as a
prognostic biomarker in sepsis and to determine a role
for antioxidant therapy.ing MDA. Mitochondria are a major source of intracel-Oxidative stress has been implicated in the pathogenesis
of sepsis-induced organ dysfunction and thus represents
a potential therapeutic target. However, because reactive
oxygen and nitrogen species have very short half-lives,
demonstration of free radical formation in human sam-
ples is exceedingly difficult. Therefore, measurements of
oxidative stress have relied on quantifying byproducts of
macromolecule oxidation. In a previous issue of Critical
Care, Lorente and colleagues demonstrated increased
levels of malondialdehyde (MDA), a marker of lipid per-
oxidation, in the serum of adults with severe sepsis [1].
Non-survivors exhibited higher MDA levels than non-
survivors. MDA levels were increased irrespective of site
of infection, type of micro-organism, or dysfunctional
organ system, suggesting that lipid peroxidation was at-
tributable to the general host response rather than a* Correspondence: WeissS@email.chop.edu
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2014pathogen- or organ-specific reaction. In survivors, serum
MDA normalized within 4 days while levels remained el-
evated in non-survivors. Increased MDA was independ-
ently associated with 30-day and 6-month all-cause
mortality. What can we hope to learn from this study
and how can we use these data to improve outcomes for
patients with sepsis?
The presence of high serum MDA levels supports the
hypothesis that increased oxidative stress, particularly
lipid peroxidation, contributes to sepsis pathophysiology.
Oxidative stress occurs when free radical production ex-
ceeds the antioxidant capacity of endogenous molecules
such as glutathione, superoxide dismutase, thioreduxin
and vitamin E. Lipid peroxidation results when fatty
acids come into contact with reactive oxygen species
(ROS), producing a series of reactive aldehydes, includ-
lular ROS because incomplete reduction of oxygen to
water through the electron transport chain produces
superoxide and hydrogen peroxide [2]. Normally, an es-
timated 1% of oxygen consumption is directed to ROS.
These molecules play an essential role in cell signaling
and immune defense [3]. In sepsis, however, uncoupled
oxidative phosphorylation and depleted antioxidant stores
are postulated mechanisms leading to an enhanced ROS
burden [4,5]. The combination of increased superoxide
and up-regulated nitric oxide production in sepsis leads to
enhanced production of peroxynitrite and other toxic re-
active nitrogen species (RNS) [2]. The net result is accu-
mulated damage to lipids, proteins, and nucleic acids that
may impede cellular function. In particular, oxidative in-
jury to lipids within plasma and mitochondrial mem-
branes can alter permeability and impair membrane-
bound receptors and enzymes. MDA and other reactive
aldehydes are among the toxic species that can disrupt
protein structure and function [6]. Because aldehydes are
released into the blood when cells are damaged by lipid
peroxidation, serum MDA has been touted as an indirect
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http://ccforum.com/content/18/2/125Lorente and colleagues hypothesized that serum MDA,
as a biomarker of oxidative stress, could provide prognos-
tic information about mortality risk in sepsis. While MDA
levels were elevated in non-survivors, the predictive utility
of this biomarker in their study was disappointing. The
area under the receiver operating characteristic curve for
serum MDA to predict 30-day mortality was a modest
0.67 (95% CI 0.61 to 0.72). The MDA cutpoint suggested
by the authors of 4.11 nmol/ml exhibited poor sensitivity
(42%, 95% CI 32 to 51%) and only moderate specificity
(82%, 95% CI 76 to 87%) for clinical use. Even with 34%
overall mortality in their study, about half of those in
whom MDA predicted death (that is, MDA ≥4.11 nmol/
ml) ultimately survived. The considerable overlap between
sepsis survivors and non-survivors limits the utility of
serum MDA levels in clinical practice, as is the case with
many other purported sepsis biomarkers [8].
Several explanations may account for the unreliability of
serum MDA levels in sepsis. First, lipid peroxidation is
not specific to sepsis and may be affected by comorbid
conditions, diet, and lifestyle behaviors. Increased blood
MDA levels occur in smokers [9] and patients with dia-
betes mellitus and hypertriglyceridemia [10,11]. Second,
the technique used by the authors to measure MDA has
important limitations. Although the thiobarbituric acid-
reactive substances (TBARS) assay is accepted as an index
of oxidative stress, this method does not specifically meas-
ure MDA or lipid peroxidation and the presence of other
aldehydes may confound the results [7]. In addition, not
all TBARS, including MDA, are derived from lipid peroxi-
dation. Use of high-performance liquid chromatography
to isolate MDA would improve specificity beyond the
spectrophotometric measurements used in this study [12].
Perhaps combining measurements of MDA with
other oxidative stress biomarkers and additional clinical
variables could improve outcome prediction for septic pa-
tients. However, whether oxidative stress causes or propa-
gates the pathogenesis of sepsis remains unclear [13].
Although verifying the occurrence of oxidative stress is
an important step, this observation cannot determine
whether lipid peroxidation or other ROS/RNS-related
damage is an important mechanism of sepsis-induced
organ injury. For decades, the observed pro-inflammatory
response characteristic of early sepsis was believed to be
the primary cause of organ injury but, to date, trials of
anti-inflammatory agents have been consistently negative
[14]. Similarly, use of antioxidant therapies in sepsis
remains an attractive but unproven strategy. While
antioxidant supplementation with vitamin E, selenium,
N-acetylcysteine, and other compounds can reduce oxida-
tive stress, clinical trials have failed to convincingly dem-
onstrate an outcome benefit [15]. Anti-oxidants targeted
to the mitochondria, a primary site of ROS/RNS produc-
tion, have shown promise in preclinical studies and maybe better suited for use in critically ill patients [4,5]. Future
studies should consider if, as Lorente and colleagues sug-
gest, biomarkers can identify patients with increased oxi-
dative stress who may derive the greatest benefit from
anti-oxidant therapy in sepsis.
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